Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Lpath Announces Filing of Shelf Registration Statement
Yahoo/MarketWire
Saturday, November 3, 2012 - 11:32am
tags:
Lpath
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, November 3, 2012 - 11:31am
tags:
Abiomed, Lexicon Pharmaceuticals, Corcept Therapeutics
Vertex's Shocking Decline Hurts Investors
Motley Fool
Saturday, November 3, 2012 - 11:30am
tags:
Vertex Pharmaceuticals
Questcor: A Case Mistaken Identity?
Wall Street Cheat Street
Saturday, November 3, 2012 - 11:30am
tags:
Questcor Pharmaceuticals, Acthar
Celgene Corporation: Today's Featured Health Care Laggard
The Street
Saturday, November 3, 2012 - 11:28am
tags:
Celgene Corporation
For Hep C Investors, What Goes Around Comes Around
Motley Fool
Saturday, November 3, 2012 - 11:28am
tags:
hepatitis C, Vertex Pharmaceuticals, Gilead Sciences, Abbott Laboratories, Idenix, Achillion
Vertex sinks as Incivek sales decline further
Yahoo/AP
Saturday, November 3, 2012 - 11:26am
tags:
Vertex Pharmaceuticals, Incivek, hepatitis C
MannKind Cuts 3Q Loss
Yahoo/Zacks
Saturday, November 3, 2012 - 11:25am
tags:
MannKind
3 Things to Watch With Seattle Genetics
Motley Fool
Saturday, November 3, 2012 - 11:24am
tags:
Seattle Genetics
Dendreon Corp Earnings: Revenue Grows Again by Double Digits, Investors Love These Numbers
Wall St. Cheat Sheet
Friday, November 2, 2012 - 11:36am
tags:
earnings, Dendreon
Merck agrees to $220M settlement of class-action lawsuit in Missouri over Vioxx
Yahoo/AP
Friday, November 2, 2012 - 11:29am
tags:
Merck, settlements, Missouri, Vioxx
Arena And Vivus To Announce Earnings On Same Day - What To Expect
Seeking Alpha
Friday, November 2, 2012 - 11:11am
tags:
Arena Pharmaceuticals, Vivus, earnings
Cel-Sci's Successful Safety Review Not Yet Factored Into Valuation
Seeking Alpha
Friday, November 2, 2012 - 11:10am
tags:
Cel-Sci, Multikine
Pfizer Sets Aside $491M For Rapamune Marketing
Pharmalot
Friday, November 2, 2012 - 11:03am
tags:
Pfizer, Rapamune, off-label
Amgen Bets on Heart Drug as Rivals Aim at Sales: Health
Bloomberg Businessweek
Friday, November 2, 2012 - 11:02am
tags:
Amgen, AMG145
Dendreon: What's The Company Worth Per Share?
Seeking Alpha
Friday, November 2, 2012 - 11:01am
tags:
Dendreon, Provenge, JNJ
Isis To Receive $1.25 Million Payment As Pfizer Continues Development Of EXC 001
Yahoo
Friday, November 2, 2012 - 10:30am
tags:
Isis Pharmaceuticals, Pfizer, antisense, Excaliard, EXC 001
Pacira Pharmaceuticals Beats on the Top Line
Motley Fool
Friday, November 2, 2012 - 10:28am
tags:
Pacira, earnings
Nestle Wins Clearance in China for Acquisition of Pfizer Unit
Bloomberg
Friday, November 2, 2012 - 10:27am
tags:
China, Pfizer, M&A, Nestle, infant nutrition
How Does The Patent Exclusivity Factor Affect The 3 Top Dividend-Paying Healthcare Companies?
Seeking Alpha
Friday, November 2, 2012 - 10:26am
tags:
patents, Amarin, AstraZeneca, Bristol-Myers Squibb, GSK

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.